Introduction: HIV-Related Opportunistic Infections in the 21st Century

Abstract

Get full access to this article

View all access options for this article.

References

Benson CA , Kaplan JE , MasurH , et al. Treating opportunistic infections among HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIVMedicine Association/Infectious Diseases Society of America. Clin Infect Dis. 2005;40:S131-S235.

Powderly W. Prophylaxis for opportunistic infections in an era of effective antiretroviral therapy. Clin Infect Dis. 2000;31:597-601.

Jones JL , Hanson DL , Dworkin MS , et al. Surveillance for AIDSdefining opportunistic illnesses, 1992-1997. MMWR CDC Surveil Summ. 1999;48(SS-2):1-22.

AIDSinfo. 2001 US Public Health Service/Infectious Diseases Society of America guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus. Available at: www.aidsinfo.nih.gov/guidelines. Accessed September 20, 2005.

Hermsen ED , Wynn HE , McNabb J . Discontinuation of prophylaxis for HIV-associated opportunistic infections in the era of highly active antiretroviral therapy. Am J Health-Syst Pharm. 2004;61:245-256.

French MA , Price P , Stone SF . Immune restoration disease after antiretroviral therapy. AIDS. 2004;18:1615-1627.

Shelburne SA , Visnegarwala F , Darcourt J , et al. Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy. AIDS. 2005;19:399-406.